Abstract
In this review we describe the genes encoding α2δ subunits, their topology and predicted structure. We then review the electrophysiological effects of α2δ subunits. It is clear from most studies that α2δ subunits increase channel density at the plasma membrane, but there is less agreement between studies and between channel subtypes concerning the effects of α2δ subunits on voltage-dependence of activation and inactivation. Most studies agree that α2δ subunits increase the kinetics of inactivation, for a number of different calcium channel subtypes. We also discuss the link between α2δ subunits and disease, particularly in terms of Ducky, the spontaneously occurring mutant mouse strain that has mutations in α2δ-2, and exhibits cerebellar ataxia and absence epilepsy. Finally, we will examine the evidence that α2δ subunits are the site of action of the anti-epileptic, anti-nociceptive drug gabapentin.
Keywords: voltage-dependence, ducky, cerebellar ataxia, epilepsy, anti-epileptic
Current Neuropharmacology
Title: Calcium Channel α2δ Subunits: Structure, Functions and Target Site for Drugs
Volume: 1 Issue: 3
Author(s): Carles Canti, Anthony Davies and Annette C. Dolphin
Affiliation:
Keywords: voltage-dependence, ducky, cerebellar ataxia, epilepsy, anti-epileptic
Abstract: In this review we describe the genes encoding α2δ subunits, their topology and predicted structure. We then review the electrophysiological effects of α2δ subunits. It is clear from most studies that α2δ subunits increase channel density at the plasma membrane, but there is less agreement between studies and between channel subtypes concerning the effects of α2δ subunits on voltage-dependence of activation and inactivation. Most studies agree that α2δ subunits increase the kinetics of inactivation, for a number of different calcium channel subtypes. We also discuss the link between α2δ subunits and disease, particularly in terms of Ducky, the spontaneously occurring mutant mouse strain that has mutations in α2δ-2, and exhibits cerebellar ataxia and absence epilepsy. Finally, we will examine the evidence that α2δ subunits are the site of action of the anti-epileptic, anti-nociceptive drug gabapentin.
Export Options
About this article
Cite this article as:
Canti Carles, Davies Anthony and Dolphin C. Annette, Calcium Channel α2δ Subunits: Structure, Functions and Target Site for Drugs, Current Neuropharmacology 2003; 1 (3) . https://dx.doi.org/10.2174/1570159033477116
DOI https://dx.doi.org/10.2174/1570159033477116 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
ATP-Binding Cassette Transporters at the Blood-Brain Barrier in Ischaemic Stroke
Current Pharmaceutical Design Synthesis of New Bis-Spiropyrazoles as Antitumor Agents under Ultrasound Irradiation
Mini-Reviews in Medicinal Chemistry Purines and Pyrimidines: Metabolism, Function and Potential as Therapeutic Options in Neurodegenerative Diseases
Current Protein & Peptide Science Pregabalin Dependence: A Case Report
Current Drug Safety Melatonin and Respiratory Diseases: A Review
Current Topics in Medicinal Chemistry Medicinal Chemistry and the Molecular Operating Environment (MOE): Application of QSAR and Molecular Docking to Drug Discovery
Current Topics in Medicinal Chemistry Could Better Phenotyping Small Vessel Disease Provide New Insights into Alzheimer Disease and Improve Clinical Trial Outcomes?
Current Alzheimer Research Glial Cells – The Key Elements of Alzheimer´s Disease
Current Alzheimer Research Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Current Pharmaceutical Design CB1 Cannabinoid Receptors and their Associated Proteins
Current Medicinal Chemistry The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators
CNS & Neurological Disorders - Drug Targets Familial Mediterranean Fever
Current Rheumatology Reviews Chemistry and Biology of Thyrotropin-Releasing Hormone (TRH) and its Analogs
Current Medicinal Chemistry EDITORIAL
Current Signal Transduction Therapy Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases
Current Pharmaceutical Design Serotonin as a Modulator of Glutamate- and GABA-Mediated Neurotransmission: Implications in Physiological Functions and in Pathology
Current Neuropharmacology Selenium and Selenoproteins: An Overview on Different Biological Systems
Current Protein & Peptide Science An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
Current Drug Metabolism Finding the Smoking Gun: Protein Tyrosine Phosphatases as Tools and Targets of Unicellular Microorganisms and Viruses
Current Medicinal Chemistry Propofol in Anesthesia. Mechanism of Action, Structure-Activity Relationships, and Drug Delivery
Current Medicinal Chemistry